(2S,3R,4R,5S,6R)-2-(4-chloro-3-((2,3-dihydro-1H-inden-5-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol | 1415471-14-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2S,3R,4R,5S,6R)-2-(4-chloro-3-((2,3-dihydro-1H-inden-5-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
• 英文别名: (2S,3R,4R,5S,6R)-2-[4-chloro-3-(2,3-dihydro-1H-inden-5-ylmethyl)phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• CAS: 1415471-14-5
• 化学式: C₂₂H₂₅ClO₅
• 分子量: 404.891
• InChiKey: JJUJVBDYEZEXMO-BDHVOXNPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  90.2
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  5-溴茚烷 在 bis-triphenylphosphine-palladium(II) chloride 、 四(三苯基膦)钯 、 palladium 10% on activated carbon 、 氢气 、 potassium acetate 、 caesium carbonate 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 12.0h， 生成 (2S,3R,4R,5S,6R)-2-(4-chloro-3-((2,3-dihydro-1H-inden-5-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
  参考文献：
  名称：

  JP5876570

  摘要：

  公开号：

文献信息

• Glycoside Derivatives and Uses Thereof
  申请人：BEBERNITZ Gregory Raymond

  公开号：US20110171159A1

  公开（公告）日：2011-07-14

  This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

  这项发明涉及由式(I)表示的化合物：其中变量如上所定义，这些化合物对治疗由钠D-葡萄糖共转运蛋白（SGLT）介导的疾病和症状，例如糖尿病，具有用处。该发明还提供了治疗这些疾病和症状的方法，以及用于治疗的组合物等。
• HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
  申请人：Shanghai Institute of Materia Medica, Chinese Academy of Sciences

  公开号：US20140088130A1

  公开（公告）日：2014-03-27

  The present invention relates to a novel hexahydrodibenzo[a,g]quinoline compound represented by general formula (I) and its derivatives, enantiomer, diastereoisomer, raceme and mixtures thereof, as well as pharmaceutically acceptable salts thereof. The present invention further relates to a method for preparing the compound, and the compound has good prevention and treatment effect on neurological diseases, especially diseases associated with dopamine receptor and 5-hydroxytryptamine receptor. The bioactivity experiment demonstrates that, the compound is expected to be developed into a novel and potent chemical entity for treating diseases associated with dopamine receptor and 5-hydroxytryptamine receptor, especially schizophrenia, Parkinson's disease, drug addiction, migraine and so on.

  本发明涉及一种由通式（I）表示的新型六氢二苯并[a,g]喹啉化合物及其衍生物、对映体、非对映体异构体、混合物以及其药学上可接受的盐。本发明还涉及一种制备该化合物的方法，该化合物对神经系统疾病具有良好的预防和治疗效果，特别是与多巴胺受体和5-羟色胺受体相关的疾病。生物活性实验证明，该化合物有望被开发成一种新型和有效的化学实体，用于治疗与多巴胺受体和5-羟色胺受体相关的疾病，特别是精神分裂症、帕金森病、药物成瘾、偏头痛等疾病。
• GLYCOSIDE DERIVATIVES AND USES THEREOF
  申请人：BEBERNITZ Gregory Raymond

  公开号：US20120178680A1

  公开（公告）日：2012-07-12

  This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

  本发明涉及由式(I)所表示的化合物：其中变量的定义如上所述，这些化合物对于治疗由钠D-葡萄糖共转运体（SGLT）介导的疾病和病状，例如糖尿病，是有用的。本发明还提供了治疗这些疾病和病状的方法、组合物等。
• NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS
  申请人：Choi Soongyu

  公开号：US20140088079A1

  公开（公告）日：2014-03-27

  The present invention relates to a compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes. The present invention also provides a method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound.

  本发明涉及一种具有二苯甲烷基团的化合物，其具有对存在于肠和肾中的钠依赖性葡萄糖共转运体2（SGLT2）的抑制活性，以及包含该化合物作为活性成分的制药组合物，用于预防或治疗代谢性疾病，尤其是糖尿病。本发明还提供了一种制备该化合物的方法，以及使用该化合物预防或治疗代谢性疾病，尤其是糖尿病的方法。
• Diphenylmethane derivatives as SGLT2 inhibitors
  申请人：GREEN CROSS CORPORATION

  公开号：US09371303B2

  公开（公告）日：2016-06-21

  A compound with a diphenylmethane moiety having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney is disclosed. A pharmaceutical composition including the compound as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes is disclosed. A method for preparing the compound, and a method for preventing or treating metabolic disorders, particularly diabetes, by using the compound is provided.

  本发明揭示了一种含有二苯甲烷基团的化合物，该化合物具有抑制存在于肠和肾中的钠依赖性葡萄糖共转运体2（SGLT2）的活性。本发明还揭示了一种包括该化合物作为活性成分的制药组合物，该组合物可用于预防或治疗代谢紊乱，特别是糖尿病。本发明还提供了一种制备该化合物的方法，以及使用该化合物预防或治疗代谢紊乱，特别是糖尿病的方法。